arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

HeartBeam, Inc.

BEAT
$0.53 ▲ +0.03 (+5.13%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
7 Visible periods
19 Metrics
Absolute Benchmarks
Price Chart
18
Health
Poor
Bearish Absolute basis
auto_awesome

Analytical Summary

On an absolute basis, HeartBeam, Inc. shows weak fundamentals, weighed down by Return on Invested Capital and FCF / Net Income. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $17.9M
Dividend Yield
Revenue Growth
Op. Margin
ROIC -812.1%
FCF / Share $-0.43
Trailing P/E
Price / Book 5.5x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

7-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-21.02M
↓ -8.1%
FCF / Share Free cash flow per share
$-0.43
↑ +21.4%

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Invested CapitalReturn on Invested Capital of -812.1% is weak on an absolute basis (target > 10%)
  • FCF / Net IncomeFCF / Net Income of 0.69x is weak on an absolute basis (target > 1x)

Health Breakdown

Cash Quality
18

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 25 quarters